Logo image of EQVA.OL

EQVA ASA (EQVA.OL) Stock Fundamental Analysis

OSL:EQVA - Euronext Oslo - NO0010708605 - Common Stock - Currency: NOK

4.96  +0.15 (+3.12%)

Fundamental Rating

4

EQVA gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 110 industry peers in the Machinery industry. EQVA has an average financial health and profitability rating. EQVA has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year EQVA was profitable.
EQVA had a positive operating cash flow in the past year.
In multiple years EQVA reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: EQVA reported negative operating cash flow in multiple years.
EQVA.OL Yearly Net Income VS EBIT VS OCF VS FCFEQVA.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

The Return On Assets of EQVA (7.32%) is better than 86.36% of its industry peers.
EQVA has a Return On Equity of 19.11%. This is amongst the best in the industry. EQVA outperforms 87.27% of its industry peers.
EQVA has a better Return On Invested Capital (21.66%) than 96.36% of its industry peers.
Industry RankSector Rank
ROA 7.32%
ROE 19.11%
ROIC 21.66%
ROA(3y)-0.99%
ROA(5y)14.41%
ROE(3y)-1.95%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EQVA.OL Yearly ROA, ROE, ROICEQVA.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

1.3 Margins

EQVA's Profit Margin of 3.81% is in line compared to the rest of the industry. EQVA outperforms 52.73% of its industry peers.
In the last couple of years the Profit Margin of EQVA has declined.
EQVA's Operating Margin of 7.08% is in line compared to the rest of the industry. EQVA outperforms 57.27% of its industry peers.
EQVA's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 51.26%, EQVA is in the better half of the industry, outperforming 67.27% of the companies in the same industry.
EQVA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.08%
PM (TTM) 3.81%
GM 51.26%
OM growth 3Y-6.53%
OM growth 5YN/A
PM growth 3Y-58.16%
PM growth 5YN/A
GM growth 3Y19.37%
GM growth 5Y25.52%
EQVA.OL Yearly Profit, Operating, Gross MarginsEQVA.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

5

2. Health

2.1 Basic Checks

EQVA has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for EQVA has been increased compared to 1 year ago.
Compared to 5 years ago, EQVA has more shares outstanding
EQVA has a better debt/assets ratio than last year.
EQVA.OL Yearly Shares OutstandingEQVA.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
EQVA.OL Yearly Total Debt VS Total AssetsEQVA.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 2.99 indicates that EQVA is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of EQVA (2.99) is better than 71.82% of its industry peers.
The Debt to FCF ratio of EQVA is 1.90, which is an excellent value as it means it would take EQVA, only 1.90 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.90, EQVA belongs to the top of the industry, outperforming 82.73% of the companies in the same industry.
A Debt/Equity ratio of 0.35 indicates that EQVA is not too dependend on debt financing.
EQVA has a Debt to Equity ratio (0.35) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 1.9
Altman-Z 2.99
ROIC/WACC2.44
WACC8.88%
EQVA.OL Yearly LT Debt VS Equity VS FCFEQVA.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

EQVA has a Current Ratio of 0.98. This is a bad value and indicates that EQVA is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.98, EQVA is doing worse than 87.27% of the companies in the same industry.
A Quick Ratio of 0.93 indicates that EQVA may have some problems paying its short term obligations.
EQVA has a Quick ratio (0.93) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.93
EQVA.OL Yearly Current Assets VS Current LiabilitesEQVA.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2

3. Growth

3.1 Past

EQVA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 241.41%, which is quite impressive.
EQVA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -69.46% yearly.
The Revenue has grown by 57.24% in the past year. This is a very strong growth!
Measured over the past years, EQVA shows a very negative growth in Revenue. The Revenue has been decreasing by -13.86% on average per year.
EPS 1Y (TTM)241.41%
EPS 3Y-69.46%
EPS 5YN/A
EPS Q2Q%39.03%
Revenue 1Y (TTM)57.24%
Revenue growth 3Y5.52%
Revenue growth 5Y-13.86%
Sales Q2Q%150.66%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EQVA.OL Yearly Revenue VS EstimatesEQVA.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 5.64, the valuation of EQVA can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of EQVA indicates a rather cheap valuation: EQVA is cheaper than 97.27% of the companies listed in the same industry.
EQVA's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.20.
Industry RankSector Rank
PE 5.64
Fwd PE N/A
EQVA.OL Price Earnings VS Forward Price EarningsEQVA.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EQVA is valued cheaper than 87.27% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, EQVA is valued cheaply inside the industry as 97.27% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 3.78
EV/EBITDA 3.86
EQVA.OL Per share dataEQVA.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

EQVA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

EQVA ASA

OSL:EQVA (5/28/2025, 7:00:00 PM)

4.96

+0.15 (+3.12%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.54%
Inst Owner ChangeN/A
Ins Owners1.69%
Ins Owner ChangeN/A
Market Cap401.81M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.2
Dividend Growth(5Y)N/A
DP23.72%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.64
Fwd PE N/A
P/S 0.25
P/FCF 3.78
P/OCF 3.45
P/B 1.26
P/tB 48.55
EV/EBITDA 3.86
EPS(TTM)0.88
EY17.74%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.31
FCFY26.49%
OCF(TTM)1.44
OCFY29.01%
SpS19.65
BVpS3.92
TBVpS0.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.32%
ROE 19.11%
ROCE 25.24%
ROIC 21.66%
ROICexc 27.86%
ROICexgc 257.21%
OM 7.08%
PM (TTM) 3.81%
GM 51.26%
FCFM 6.69%
ROA(3y)-0.99%
ROA(5y)14.41%
ROE(3y)-1.95%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y43.23%
ROICexcg growth 5YN/A
ROICexc growth 3Y-31.72%
ROICexc growth 5YN/A
OM growth 3Y-6.53%
OM growth 5YN/A
PM growth 3Y-58.16%
PM growth 5YN/A
GM growth 3Y19.37%
GM growth 5Y25.52%
F-Score6
Asset Turnover1.92
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 1.9
Debt/EBITDA 0.86
Cap/Depr 67.63%
Cap/Sales 0.64%
Interest Coverage 5.71
Cash Conversion 91.31%
Profit Quality 175.32%
Current Ratio 0.98
Quick Ratio 0.93
Altman-Z 2.99
F-Score6
WACC8.88%
ROIC/WACC2.44
Cap/Depr(3y)46.03%
Cap/Depr(5y)117.5%
Cap/Sales(3y)0.84%
Cap/Sales(5y)1.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)241.41%
EPS 3Y-69.46%
EPS 5YN/A
EPS Q2Q%39.03%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)57.24%
Revenue growth 3Y5.52%
Revenue growth 5Y-13.86%
Sales Q2Q%150.66%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y900.06%
EBIT growth 3Y-1.37%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y287.99%
FCF growth 3Y-30.53%
FCF growth 5YN/A
OCF growth 1Y328.57%
OCF growth 3Y-30.04%
OCF growth 5YN/A